Physician profile
Timothy S Spaulding
NPI 1306882022
$964.99
in general payments reported to CMS, 2019-2025
18 companies · $93.56 in 2025
The $93.56 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $203 · 2020: $53.35 · 2022: $93.49 · 2023: $328 · 2024: $194 · 2025: $93.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $615.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $614.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $163.71 | 2019-2025 | Veozah |
| Channel Medsystems, INC. | $150.45 | 2023-2024 | |
| Aspira Women'S Health INC | $119.28 | 2022-2023 | Ova1 |
| Abbvie INC. | $97.78 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Allergan, INC. | $72.58 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $51.25 | 2023-2025 | Gardasil 9, Gardasil |
| Pacira Pharmaceuticals Incorporated | $48.16 | 2022-2024 | Exparel |
| Pfizer INC. | $45.21 | 2023-2024 | |
| Shield Therapeutics INC | $37.06 | 2024-2025 | |
| Organon LLC | $36.96 | 2023-2025 | Nexplanon |
| Exeltis, USA INC. | $34.63 | 2023 | Slynd |
| Hologic Sales and Service, LLC | $21.08 | 2025 | Acessa Provu System |
| Sumitomo Pharma America, INC. | $17.08 | 2024 | Myfembree |
| Lupin INC. | $16.76 | 2020 | |
| Duchesnay USA Incorporated | $16.43 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $13.40 | 2019 | |
| Novo Nordisk INC | $12.28 | 2019 | |
| Minerva Surgical, INC | $10.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Spaulding listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.